Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 02 Oct 2026 for Under Armour, Inc.. Read the official filing
Filing timeline
BuySaleDouglas E. Coltharp
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Douglas E. Coltharp: trading record in brief
This profile gathers the share dealings of Douglas E. Coltharp across 2 companies, led by Encompass Health Corp and Under Armour, Inc. We count 93 filings; the first trade dates from 4 January 2016 and the latest from 1 October 2026.
The open-market record consists of 6 sales worth €8.1M, with no purchase. The rest of the record consists of 71 share grants and 9 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 2 October 2026, reports a share grant in Under Armour, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas E. Coltharp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations93 total
7,864.24 shares0Class C Common StockSEC:0001336917-26-000143:0
18,869 shares@ US$125.380.019% mcap13.7% of flowEncompass Health Common StockSEC:0000785161-26-000192:0
5,575.12 shares0Class C Common StockSEC:0001336917-26-000088:0
6,361.61 shares0Class C Common StockSEC:0001336917-26-000046:0
776 shares@ US$107.880.5% of flowEncompass Health Common StockSEC:0000785161-26-000083:0
14,818 shares@ US$106.158.9% of flowEncompass Health Common StockSEC:0000785161-26-000071:0
16,708 shares@ US$107.1510.1% of flowEncompass Health Common StockSEC:0000785161-26-000053:0
37,588 shares0Encompass Health Common StockSEC:0000785161-26-000043:0
7,026.63 shares0Class C Common StockSEC:0001336917-26-000002:0
7,300.2 shares0Class C Common StockSEC:0001336917-25-000177:0
30,674.85 shares0Class C Common StockSEC:0001336917-25-000153:0
27,480 shares0Encompass Health Common StockSEC:0001127602-25-020840:0
5,285.61 shares0Class C Common StockSEC:0001336917-25-000114:0
16,075 shares@ US$29.062.7% of flowEncompass Health Common StockSEC:0001127602-25-012782:0
27,500 shares@ US$32.945.3% of flowEncompass Health Common StockSEC:0001127602-25-012782:1
26,239 shares@ US$114.7817.7% of flowEncompass Health Common StockSEC:0001127602-25-012782:2
13,402 shares@ US$115.519.1% of flowEncompass Health Common StockSEC:0001127602-25-012782:3
3,934 shares@ US$116.362.7% of flowEncompass Health Common StockSEC:0001127602-25-012782:4
5,840.16 shares0Class C Common StockSEC:0001336917-25-000030:0
776 shares@ US$100.140.5% of flowEncompass Health Common StockSEC:0001127602-25-007392:0
927 shares@ US$97.530.6% of flowEncompass Health Common StockSEC:0001127602-25-006854:0
4,557 shares0Encompass Health Common StockSEC:0001127602-25-006200:0
4,893.54 shares0Class C Common StockSEC:0001336917-25-000002:0
12,438 shares@ US$92.357.4% of flowEncompass Health Common StockSEC:0001127602-25-000302:0
65,229 shares0Encompass Health Common StockSEC:0001127602-24-027198:0
25 of 93 declarations
